Blankenberg, F.G., et al., “Imaging of Apoptosis (Programmed Cell Death) with 99mTc Annexin V,” The Journal of Nuclear Medicine, vol. 40, No. 1, Jan. 1999, pp. 184-191. |
Blankenberg, F.G., et al., “In Vivo Detection and Imaging of Phosphatidylserine Expression During Programmed Cell Death,” Proceedings of the National Academy of Sciences, vol. 95, May 1998, pp. 6349-6354. |
George, A.J.T., et al., “Radiometal Labeling of Recombinant Proteins by a Genetically Engineered Minimal Chelation Site: Technetium-99m Coordination by Single-Chain Fv Antibody Fusion Proteins Through a C-Terminal Cysteinyl Peptide,” Proceedings of the National Academy of Sciences, vol. 92, Aug. 1995, pp. 8358-8362. |
Huston, J.S., et al., “Single-Chain Fv Radioimmunotargeting,” The Quarterly Journal of Nuclear Medicine, vol. 40, No. 3, Sep. 1996, pp. 320-333. |
Liberatore, M., et al., “Efficient One-Step Direct Labelling of Recombinant Antibodies with Technetium-99m,” European Journal of Nuclear Medicine, vol. 22, No. 11, Nov. 1995, pp. 1326-1329. |
Stratton, J.R., et al., “Selective Uptake of Radiolabeled Annexin V on Acute Porcine Left Atrial Thrombi,” Circulation, vol. 92, No. 10, Nov. 15, 1995, pp. 3113-3121. |
Vriens, P.W., et al., “The Use of Technetium TC99M Annexin V for In Vivo Imaging of Apoptosis During Cardiac Allograft Rejection,” The Journal of Thoracic and Cardiovascular Surgery, vol. 116, No. 5, Nov. 1998, pp. 844-853. |
Giblin, M.F., et al., “Synthesis and Characterization of Rhenium-Complexed α-Melanotropin Analogs,” Bioconjugate Chem., vol. 8, No. 3, 1997, pp. 347-353. |
Stalteri, M.A., et al., “Comparison of the Stability of Technetium-Labeled Peptides to Challenge with Cysteine,” Bioconjugate Chem., vol. 10, No. 1, 1999, pp. 130-136. |